VNRX
insider transactionsVOLITIONRX LTD — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·F
Secretary
$750
3.9K sh · $0.19
Own -1%
-
Other·F
GC - Volition Diagnostics
$1.3K
7.0K sh · $0.19
Own -2%
-
Other·F
Chief Scientific Officer
$1.0K
5.3K sh · $0.19
Own -1%
-
Other·F
Chief Commercial Officer
$998
5.3K sh · $0.19
Own -2%
-
Other·F
Secretary
$707
3.3K sh · $0.21
Own -1%
-
Other·F
GC - Volition Diagnostics
$1.2K
5.9K sh · $0.21
Own -1%
-
Other·F
Chief Commercial Officer
$486
2.3K sh · $0.21
Own -1%
-
Grant·A
Director
$0
178.0K sh
Own +237%
-
Grant·A
Secretary
$0
119.0K sh
Own +73%
-
Grant·A
President and CEO
$0
486.0K sh
Own +18%
-
Grant·A
GC - Volition Diagnostics
$0
187.0K sh
Own +80%
-
Grant·A
Director
$0
178.0K sh
Own +139%
-
Grant·A
Chief Scientific Officer
$0
149.0K sh
Own +35%
-
Grant·A
Jasmine Kway KEY
CEO - Singapore Volition
$0
173.0K sh
Own +70%
-
Grant·A
Director
$0
178.0K sh
Own +17%
-
Grant·A
Terig Hughes KEY
Chief Financial Officer
$0
202.0K sh
Own +42%
-
Grant·A
Chief Commercial Officer
$0
149.0K sh
Own +78%
-
Grant·A
Group Chief Marketing Officer
$0
142.0K sh
Own +78%
-
Other·F
Secretary
$911
3.2K sh · $0.29
Own -2%
-
Other·F
GC - Volition Diagnostics
$1.6K
5.6K sh · $0.29
Own -2%
-
Other·F
Chief Commercial Officer
$573
2.0K sh · $0.29
Own -1%
-
Grant·A
Director
$0
90.0K sh
Own +6%
-
Grant·A
Director
$0
12.0K sh
Own +19%
-
Grant·A
Secretary
$0
28.2K sh
Own +21%
-
Grant·A
President and CEO
$0
74.7K sh
Own +3%
-
Grant·A
GC - Volition Diagnostics
$0
44.7K sh
Own +23%
-
Grant·A
Director
$0
12.0K sh
Own +10%
-
Grant·A
Chief Scientific Officer
$0
35.4K sh
Own +9%
-
Grant·A
Jasmine Kway KEY
CEO - Singapore Volition
$0
42.0K sh
Own +21%
-
Grant·A
Director
$0
12.0K sh
Own +1%
-
Grant·A
Terig Hughes KEY
Chief Financial Officer
$0
49.2K sh
Own +11%
-
Grant·A
Director
$0
12.0K sh
Own +37%
-
Grant·A
Chief Commercial Officer
$0
38.1K sh
Own +25%
-
Grant·A
Director
$0
12.0K sh
Own +5%
-
Grant·A
CEO - Volition Veterinary
$0
53.4K sh
Own +17%
-
Grant·A
Group Chief Marketing Officer
$0
33.9K sh
Own +23%
-
Grant·A
Director
$0
12.0K sh
Own +22%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Mar 17, 2026 | Rodney Gerard Rootsaert | Other F | 3.9K | $750 |
| Mar 17, 2026 | Nicholas Plummer | Other F | 7.0K | $1.3K |
| Mar 17, 2026 | Jacob Vincent Micallef | Other F | 5.3K | $1.0K |
| Mar 17, 2026 | Gael Forterre | Other F | 5.3K | $998 |
| Mar 1, 2026 | Rodney Gerard Rootsaert | Other F | 3.3K | $707 |
| Mar 1, 2026 | Nicholas Plummer | Other F | 5.9K | $1.2K |
| Mar 1, 2026 | Gael Forterre | Other F | 2.3K | $486 |
| Feb 26, 2026 | Ethel Rubin | Grant A | 178.0K | $0 |
| Feb 26, 2026 | Rodney Gerard Rootsaert | Grant A | 119.0K | $0 |
| Feb 26, 2026 | Cameron John Reynolds KEY | Grant A | 486.0K | $0 |
| Feb 26, 2026 | Nicholas Plummer | Grant A | 187.0K | $0 |
| Feb 26, 2026 | Kim Nguyen | Grant A | 178.0K | $0 |
| Feb 26, 2026 | Jacob Vincent Micallef | Grant A | 149.0K | $0 |
| Feb 26, 2026 | Jasmine Kway KEY | Grant A | 173.0K | $0 |
| Feb 26, 2026 | Guy Archibald Innes | Grant A | 178.0K | $0 |
| Feb 26, 2026 | Terig Hughes KEY | Grant A | 202.0K | $0 |
| Feb 26, 2026 | Gael Forterre | Grant A | 149.0K | $0 |
| Feb 26, 2026 | Ann-Louise Batchelor | Grant A | 142.0K | $0 |
| Feb 1, 2026 | Rodney Gerard Rootsaert | Other F | 3.2K | $911 |
| Feb 1, 2026 | Nicholas Plummer | Other F | 5.6K | $1.6K |
| Feb 1, 2026 | Gael Forterre | Other F | 2.0K | $573 |
| Jan 22, 2026 | Timothy I Still | Grant A | 90.0K | $0 |
| Jan 22, 2026 | Ethel Rubin | Grant A | 12.0K | $0 |
| Jan 22, 2026 | Rodney Gerard Rootsaert | Grant A | 28.2K | $0 |
| Jan 22, 2026 | Cameron John Reynolds KEY | Grant A | 74.7K | $0 |
| Jan 22, 2026 | Nicholas Plummer | Grant A | 44.7K | $0 |
| Jan 22, 2026 | Kim Nguyen | Grant A | 12.0K | $0 |
| Jan 22, 2026 | Jacob Vincent Micallef | Grant A | 35.4K | $0 |
| Jan 22, 2026 | Jasmine Kway KEY | Grant A | 42.0K | $0 |
| Jan 22, 2026 | Guy Archibald Innes | Grant A | 12.0K | $0 |
| Jan 22, 2026 | Terig Hughes KEY | Grant A | 49.2K | $0 |
| Jan 22, 2026 | Mickie Henshall | Grant A | 12.0K | $0 |
| Jan 22, 2026 | Gael Forterre | Grant A | 38.1K | $0 |
| Jan 22, 2026 | Alan Colman | Grant A | 12.0K | $0 |
| Jan 22, 2026 | Salvatore Thomas Butera KEY | Grant A | 53.4K | $0 |
| Jan 22, 2026 | Ann-Louise Batchelor | Grant A | 33.9K | $0 |
| Jan 22, 2026 | Phillip Barnes | Grant A | 12.0K | $0 |
About VNRX insider trading
This page tracks insider transactions for VOLITIONRX LTD (VNRX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.